Local pulmonary administration of factor viia (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm

Biologics: Targets and Therapy

Volumn 6, Issue , 2012, Pages 37-46

  Heslet, Lars ^a   Nielsen, Jørn Dalsgaard ^b   Nepper Christensen, Steen ^b  

^a Serendex ApS   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Algorithm; Biologics; Blast lung injury; Bronchoalveolar lavage; Coagulation factor FVIIa; Diagnosis; Diffuse alveolar hemorrhage; Hemosiderosis; Local pulmonary treatment; New treatment recommendation

Indexed keywords

CORTICOSTEROID; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STEROID;

ACUTE LUNG INJURY; ADJUVANT THERAPY; AUTOIMMUNE DISEASE; BLAST INJURY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CAUSE OF DEATH; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; DIFFUSE ALVEOLAR HEMORRHAGE; DISEASE SEVERITY; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOSTASIS; HUMAN; LOW DRUG DOSE; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; LUNG LAVAGE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

EID: 84866767321     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Rose RM, Kobzik L, Dushay K, et al. The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates. Am Rev Respir Dis. 1992;146(5 Pt 1): 1279-1286
2. Choi G, Vlaar APJ, Schouten M, et al. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation. Eur Respir J. 2007;30(3):423-428
3. Heslet L, Andersen JS, Sengeløv H, Dahlbäck B, Dalsgaard-Nielsen J. Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome. Biologics. 2007;1(4): 465-472
4. Heslet L. Look on the "air side" in pneumonia. Crit Care Med. 2009; 37(2):774-775
5. Afessa B, Tefferi A, Litzow MR, et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002;166(5):64-645
6. Agustí C, Ramirez J, Picado C, et al. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. Am J Respir Crit Care Med. 1995;151(4):1006-1010
7. Afessa B, Tefferi A, Litzow MR, Peters SG. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002;166(10):1364-1368
8. Majhail NS, Parks K, Defor TE, Weisdorf DJ. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant. 2006;12(10):1038-1046
9. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992;67(2):117-122
10. Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med. 2003;31(6):1715-1721
11. Jackson SR, Tweeddale MG, Barnett MJ, et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998;21(7):697-704
12. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis. 1992; 145(3):510-514
13. Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest. 2002;121(1):185-188
14. Scott PH, Morgan TJ, Durrant S, Boots RJ. Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants. Anaesth Intensive Care. 2002;30(3): 289-294
15. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med. 1996;125(8):625-633
16. Torrecilla C, Cortés JL, Chamorro C, et al. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med. 1988;14(4):393-398
17. Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. Am Rev Respir Dis. 1988;137(3):682-687
18. Fouret PJ, Touboul JL, Mayaud CM, Akoun GM, Roland J. Pulmonary Kaposi's sarcoma in patients with acquired immune deficiency syndrome: a clinicopathological study. Thorax. 1987;42(4):262-268
19. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76(3): 192-202
20. Teague CA, Doak PB, Simpson IJ, Rainer SP, Herdson PB. Goodpasture's syndrome: an analysis of 29 cases. Kidney Int. 1978;13(6): 492-504
21. Wojno KJ, Vogelsang GB, Beschorner WE, Santos GW. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation. 1994; 57(1):88-92
22. Newsome BR, Morales JE. Diffuse alveolar hemorrhage. South Med J. 2011;104(4):269-274
23. Mackenzie IM, Tunnicliffe B. Blast injuries to the lung: epidemiology and management. Philos Trans R Soc Lond B Biol Sci. 2011;366(1562): 295-299
24. Elsayed NM, Gorbunov NV, Kagan VE. A proposed biochemical mechanism involving hemoglobin for blast overpressure-induced injury. Toxicology. 1997;121(1):81-90
25. Gorbunov NV, Asher LV, Ayyagari V, Atkins JL. Inflammatory leukocytes and iron turnover in experimental hemorrhagic lung trauma. Exp Mol Pathol. 2006;80(1):11-25
26. Elsayed NM, Gorbunov NV. Pulmonary biochemical and histological alterations after repeated low-level blast overpressure exposures. Toxicol Sci. 2007;95(1):289-296
27. Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med. 2004;140(6): 493-494
28. Dabar G, Harmouche C, Jammal M. Eff icacy of recombinant activated factor VII in diffuse alveolar haemorrhage. Rev Mal Respir. 2011;28(1):106-111. [Article in French.]
29. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant. 2002;30(12):975-978
30. Pastores SM, Papadopoulos E, Voigt L, Halpern NA. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa. Chest. 2003;124(6): 2400-2403
31. Heslet L, Nielsen JD, Levi M, Sengeløv H, Johansson PI. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care. 2006;10(6):R177
32. Estella A, Jareño A, Perez-Bello Fontaiña L. Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories. Cases J. 2008;1(1):150
33. Grochova M, Kalnasova B, Firment J, et al. Pulmonary administration of activated recombinant factor VII. Bratisl Lek Listy. 2011;112(1): 29-33
34. Colin AA, Shafieian M, Andreansky M. Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child. Pediatr Pulmonol. 2010;45(4):411
35. Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in US hospitals: analysis of hospital records. Ann Intern Med. 2011;154(8):516-522
36. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363(19):1791-1800
37. Stanworth SJ, Birchall J, Doree CJ, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2007;(2):CD005011
38. Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol. 2004;38(5):369-378.